Federal Act
on Medicinal Products and Medical Devices
(Therapeutic Products Act, TPA)


Open article in different language:  DE  |  FR  |  IT
Art. 69 Tasks

1 The Agency shall ac­com­plish the tasks as­signed to it un­der this Act and oth­er fed­er­al acts.188

1bis The Fed­er­al Coun­cil may, against pay­ment, del­eg­ate oth­er tasks to the Agency which are closely re­lated to the tasks as­signed to it by law and which do not im­pair its per­form­ance.189

2 The Agency may, in re­turn for pay­ment, provide ser­vices to oth­er au­thor­it­ies and in­ter­na­tion­al or­gan­isa­tions with­in the scope of its tasks un­der this Act, provided that such ser­vices do not jeop­ard­ise the in­de­pend­ence of the Agency.190

3 The Fed­er­al Coun­cil may ask the Agency to par­ti­cip­ate in the draft­ing of le­gis­la­tion in the thera­peut­ic products sec­tor.

4 The Agency is the na­tion­al cent­ral and con­tact point pur­su­ant to Art­icles 17 para­graph 3 and 22 para­graph 2 of the Coun­cil of Europe Con­ven­tion of 28 Oc­to­ber 2011191 on the coun­ter­feit­ing of med­ic­al products and sim­il­ar crimes in­volving threats to pub­lic health. It shall main­tain con­tacts with the des­ig­nated con­tact points in oth­er coun­tries.192

188 Amended by No I of the FA of 18 March 2016, in force since 1 Jan. 2019 (AS 2017 2745, 2018 3575; BBl 2013 1).

189 In­ser­ted by No I of the FA of 18 March 2016, in force since 1 Jan. 2019 (AS 2017 2745, 2018 3575; BBl 2013 1).

190 Amended by No I of the FA of 18 March 2016, in force since 1 Jan. 2019 (AS 2017 2745, 2018 3575; BBl 2013 1).

191 SR 0.812.41

192 In­ser­ted by An­nex No 2 of the FD of 29 Sept. 2017 (Medicrime Con­ven­tion), in force since 1 Jan. 2019 (AS 2018 4771; BBl 2017 3135).

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback